Cerity Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Sell
25,817
-3,172
-11% -$67.8K ﹤0.01% 2464
2026
Q1
$586K Buy
28,989
+900
+3% +$20K ﹤0.01% 2182
2025
Q4
$538K Sell
28,089
-9,699
-26% -$204K ﹤0.01% 2054
2025
Q3
$910K Sell
37,788
-29
-0.1% -$677 ﹤0.01% 1639
2025
Q2
$736K Buy
+37,817
New +$559K ﹤0.01% 1667
2024
Q4
– Sell
-13,721
Closed -$310K – 2417
2024
Q3
$310K Buy
+13,721
New +$314K ﹤0.01% 2040
2024
Q2
– Sell
-7,012
Closed -$231K – 2223
2024
Q1
$231K Buy
+7,012
New +$239K ﹤0.01% 2025

Other funds holding ADNT

Cerity Partners's ADNT Position: Q2 2026 in Review

Cerity Partners reduced its Adient (ADNT) stake by 11% in Q2 2026, selling an estimated $67.8K and leaving 25,817 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Cerity Partners first reported a position in ADNT in Q1 2024 and has held it in 7 quarters since. The position peaked at $910K in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Cerity Partners held 25,817 shares of Adient worth $475K as of Q2 2026.
  • Cerity Partners sold 3,172 Adient shares in Q2 2026, an estimated $67.8K.
  • Adient made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2464 holding.
  • Cerity Partners first reported a position in Adient in Q1 2024 and has held it in 7 quarters since.
  • Cerity Partners's Adient position peaked at $910K in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.